• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Healthcare·ALGAE.PA
Share

Fermentalg SA Stocks

€ 0.39Last Updated 20.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 53.88M

€ 0.39
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Fermentalg SA, established in 2009 and headquartered in Libourne, France, is an internationally operating company specializing in the research, manufacturing, and sale of functional ingredients sourced from microalgae. These offerings serve various industries, including food, health, nutritional supplements, and environmental protection. Their product portfolio features DHA ORIGINS, a plant-derived DHA oil; KALVEA PLUS, a high-protein algal concentrate tailored for aquaculture feed; Everzure, a naturally occurring, acid-stable blue colorant; BLUE ORIGINS AOX, known for its antioxidant and anti-inflammatory benefits; BLUE ORIGIN, another natural coloring agent; and advanced clean air solutions designed for industrial CO2 capture.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of ALGAE.PA is 0.56 and suggests 39.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 16:10

Shares of software developer Braze soared 50%. Salesforce is set to acquire it for the "wow factor."

21.10.2026 15:51

It's Not Just the War: Morgan Stanley Doesn't Expect the Fuel Market to Ease Until Mid-2027

21.10.2026 15:46

Morning in New York: Stress Tests for the Tech Sector Continue

21.10.2026 15:46

Losses Exceeding $80 Billion and Rapidly Rising Costs: What the WSJ Learned from Anthropic's Prospectus

21.10.2026 14:58

Where Can You Drive the Tesla Roadster? This and Other Questions About Musk's "Rocket on Wheels"

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026